Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer

Fig. 2

CXCR4 expression in MEF and CT26 cell lines. (A) The bar graph illustrates the relative gene expression levels of CXCR4 in CT26 and MEF cell lines. (B) The bar graph represents the quantity of CXCR4-positive cells within CT26 and MEF cell populations, as quantified by flow cytometry. Below, the bar graph shows representative flow cytometry dot plots, showcasing the percentage of CXCR4-positive cells in each cell line (5.2% for MEF and 32% for CT26). The experiments were performed in triplicate. The results are expressed as the mean ± standard deviation (SD) from three independent experiments, with ** denoting statistical significance at P < 0.01 and **** indicating a statistical significance level of P < 0.0001

Back to article page